JP2022528053A5 - - Google Patents

Info

Publication number
JP2022528053A5
JP2022528053A5 JP2021557014A JP2021557014A JP2022528053A5 JP 2022528053 A5 JP2022528053 A5 JP 2022528053A5 JP 2021557014 A JP2021557014 A JP 2021557014A JP 2021557014 A JP2021557014 A JP 2021557014A JP 2022528053 A5 JP2022528053 A5 JP 2022528053A5
Authority
JP
Japan
Prior art keywords
psma
binding protein
binding
seq
protein according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021557014A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022528053A (ja
JP7498971B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/060043 external-priority patent/WO2020208083A1/en
Publication of JP2022528053A publication Critical patent/JP2022528053A/ja
Publication of JP2022528053A5 publication Critical patent/JP2022528053A5/ja
Application granted granted Critical
Publication of JP7498971B2 publication Critical patent/JP7498971B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021557014A 2019-04-10 2020-04-08 がん診断及び治療のための新規ｐｓｍａ特異的結合タンパク質 Active JP7498971B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19168525.4 2019-04-10
EP19168525 2019-04-10
PCT/EP2020/060043 WO2020208083A1 (en) 2019-04-10 2020-04-08 Novel psma specific binding proteins for cancer diagnosis and treatment

Publications (3)

Publication Number Publication Date
JP2022528053A JP2022528053A (ja) 2022-06-08
JP2022528053A5 true JP2022528053A5 (https=) 2024-02-22
JP7498971B2 JP7498971B2 (ja) 2024-06-13

Family

ID=66286079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021557014A Active JP7498971B2 (ja) 2019-04-10 2020-04-08 がん診断及び治療のための新規ｐｓｍａ特異的結合タンパク質

Country Status (12)

Country Link
US (1) US12611441B2 (https=)
EP (2) EP3953375B9 (https=)
JP (1) JP7498971B2 (https=)
KR (1) KR102934740B1 (https=)
CN (1) CN113677698B (https=)
AU (1) AU2020271959B2 (https=)
BR (1) BR112021017863A2 (https=)
CA (1) CA3136229A1 (https=)
IL (1) IL286791A (https=)
SG (1) SG11202110940YA (https=)
WO (1) WO2020208083A1 (https=)
ZA (1) ZA202108843B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023285164A1 (en) * 2021-07-13 2023-01-19 Navigo Proteins Gmbh Affinity ligands for the purification and detection of ubiquitin muteins
CN114569744A (zh) * 2022-03-08 2022-06-03 安徽淮仁堂药业股份有限公司 一种锝前列腺标特异性膜抗原显像剂试剂盒及其制备方法和应用
CN116041435B (zh) * 2023-02-21 2023-07-07 浙江农林大学 一种具有2019新型冠状病毒主蛋白酶抑制活性的榛仁蛋白衍生肽及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035839A2 (en) * 2001-10-24 2003-05-01 Dgi Biotechnologies, Inc. Target specific screening andits use for identifying target binders
WO2006028429A2 (en) 2002-08-05 2006-03-16 The Johns Hopkins University Peptides for targeting the prostate specific membrane antigen
DE10324447A1 (de) * 2003-05-28 2004-12-30 Scil Proteins Gmbh Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin
RU2553333C2 (ru) * 2009-12-14 2015-06-10 Сцил Протеинс Гмбх Способ идентификации гетеромультимерных модифицированных убиквитиновых белков со способностью связываться с лигандами
WO2012171541A1 (en) * 2011-06-15 2012-12-20 Scil Proteins Gmbh Human fusion proteins comprising interferons and hetero-dimeric modified ubiquitin proteins
JP6738340B2 (ja) * 2015-02-06 2020-08-12 ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ 新規なｅｇｆｒ結合タンパク質
WO2016124670A1 (en) * 2015-02-06 2016-08-11 Scil Proteins Gmbh Novel binding proteins comprising a ubiquitin mutein and antibodies or antibody fragments
US10844111B2 (en) * 2015-05-06 2020-11-24 Janssen Biotech, Inc. Prostate specific membrane antigen binding fibronectin type III domains
WO2017013136A1 (en) * 2015-07-20 2017-01-26 Scil Proteins Gmbh Novel binding proteins based on di-ubiquitin muteins and methods for generation
DK3325514T3 (da) * 2015-07-20 2019-12-16 Navigo Proteins Gmbh Her2-bindende proteiner baseret på di-ubiquitin-muteiner
WO2017149002A1 (en) 2016-03-03 2017-09-08 Navigo Proteins Gmbh Novel fusion proteins for capturing of cells
WO2023285164A1 (en) * 2021-07-13 2023-01-19 Navigo Proteins Gmbh Affinity ligands for the purification and detection of ubiquitin muteins

Similar Documents

Publication Publication Date Title
JP7417432B2 (ja) 新規リンカー、その製造方法およびその応用
JP3280376B2 (ja) 多価抗原結合性蛋白質
JP7680745B2 (ja) １価ｃｃａｐ生成物の製造方法
JP2021502810A5 (https=)
WO2018230257A1 (ja) ＩｇＧ結合ペプチド、及び該ペプチドによる抗体の特異的修飾
JPH02500329A (ja) ターゲット化多機能蛋白質
JP2022528053A5 (https=)
JP2021521822A5 (https=)
JPH02501112A (ja) 免疫親和性による精製方法
WO2002066514A3 (en) Artificial fusion proteins with reduced immunogenicity
CN105142675A (zh) 通过序列特异性转肽酶制备免疫配体/效应分子结合物的方法
JPH0259128B2 (https=)
JP2019511201A5 (https=)
JP2024507540A5 (https=)
JP2024509241A5 (https=)
JP2024513559A5 (https=)
AU6757098A (en) Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
JP5718574B2 (ja) ペプチドのスクリーニング方法
Remy et al. A new radioligand for the epidermal growth factor receptor: 111In-labeled human epidermal growth factor derivatized with a bifunctional metal-chelating peptide
Mhidia et al. Synthesis of Peptide− Protein Conjugates Using N-Succinimidyl Carbamate Chemistry
JP2021504493A (ja) 抗体と生理活性物質の接合方法
JPH02152990A (ja) 細胞接着活性ポリペプチド
JP2019523782A5 (https=)
CA2096953A1 (en) Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
JPS62502687A (ja) 消化管起源の悪性細胞のｉｎ　ｖｉｔｒｏ検出方法